Category: Generics Drugs
Global Generics Drugs
-
Branded Generics Market by Product (Trade Named Generics, Value-Added), Drug Type (Alkylating Agents, Anti-depressants, Anti-epileptics), Route of Administration, Indication, Distribution Channel - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 494.29 billion in 2024, at a CAGR 14.66% to reach USD 1,126.43 billion by 2030. Branded generic drugs refer to medications that are bioequivalent to the original ... Read More
-
Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.03 billion in 2024, at a CAGR 12.26% to reach USD 92.55 billion by 2030. The pharmaceutical market, comprising the discovery, development, production, and distribution of a ... Read More
-
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 36.58 billion in 2024, at a CAGR 10.64% to reach USD 67.22 billion by 2030. Generic injectables are non-branded pharmaceuticals that are administered by injection and have the same ... Read More
-
Pulmonary Drugs Market by Drug Class (Anti-Cholinergic Agents, Anti-Leukotrienes, Antihistamines), Indication (Allergic Rhinitis, Asthma, Chronic Obstructive Pulmonary Disease), Drug Type, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 79.35 billion in 2023 and expected to reach USD 86.14 billion in 2024, at a CAGR 8.03% to reach USD 136.27 billion by 2030. The pulmonary drugs market encompasses a wide range of therapeutic ... Read More
-
Digital Dose Inhaler Market by Product (Dry Powder Inhalers, Metered Dose Inhalers), Type (Branded Medication, Generics Medication), Distribution Channel, Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.15 billion in 2024, at a CAGR 10.33% to reach USD 2.08 billion by 2030. The digital dose inhaler market encompasses the sector for medical devices that ... Read More
-
Healthcare Distribution Market - By Type (Pharmaceutical [OTC, Generic, Branded Drugs], Biopharmaceutical [Vaccines, Monoclonal Antibodies], & Medical Device Distribution Services), End-use (Hospital, Retail Pharmacies) – Global Forecast (2024 – 2032)
... demonstrate a 7.1% CAGR between 2024 and 2032, propelled by innovations in warehouse management systems (WMS) and a heightened focus on patient safety. Advanced WMS technologies improve efficiency, accuracy, and regulatory compliance, ensuring the secure ... Read More
-
Global Active Pharmaceutical Ingredients (API) Market Report by Drug Type (Innovative, Generic), Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Application (Cardiovascular Diseases, Oncology, Central Nervous System and Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Applications), Regions and Company Analysis 2024-2032
... Other Applications), Regions and Company Analysis 2024-2032 Active Pharmaceutical Ingredients Market is envisioned at US$ 212.12 billion in 2023 and is anticipated to attain US$ 377.05 billion via 2032, growing at a CAGR of % ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029
... market is projected to reach USD 238.3 billion by 2029 from USD 163.5 billion in 2024, at a CAGR of 7.8% during the forecast period of 2024 to 2029. The growth of this market can ... Read More
-
Global Pharmaceutical Continuous Manufacturing
... adoption in specific areas such as small molecule oral solid dosage forms and large molecules, the market has consistently demonstrated robust year-on-year growth. Projections indicate that the global pharmaceutical continuous manufacturing market will experience a ... Read More
-
Specialty Generics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 76.65 billion in 2023, and the market is now projected to grow from USD 86.86 billion in 2024 to USD 274.76 billion by 2032, exhibiting a CAGR of 15.5% during the forecast period of 2024-2032. ... Read More
-
Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033
... Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs4) By End-User: Biotech And Pharma Companies; Research InstitutionsCovering: BASF SE; Evonik Industries AG; Pfizer Inc.; Arkema Inc.; Koninklijke DSM N.V. Pharmaceutical Intermediates Global ... Read More
-
Global Generic drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
2024 Global: Branded Generics - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
Gastrointestinal Diseases Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Anti-inflammatory and immunosuppressors, Acid neutralizers, Others), By Type (Branded, Generics), by Region, Country, Segment, and Companies, 2024-2030
... size is poised to register 5.05% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gastrointestinal Diseases Therapeutics market By Drug Class ... Read More
-
Branded Generics Market Size, Trends, Analysis, and Outlook By Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Others), By Application (Oncology, Cardiovascular Diseases, Neurological Diseases, Gastrointestinal Diseases, Dermatological Diseases, Acute and Chronic Pain, Others), By Route of Administration (Topical, Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... and Chronic Pain, Others), By Route of Administration (Topical, Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Branded Generics market size is ... Read More
-
Gastrointestinal Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Gastrointestinal Therapeutics market size is poised to register ... Read More
-
Antibiotics Market Size, Trends, Analysis, and Outlook By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, Others), By Type (Branded Antibiotics, Generic Antibiotics), By Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Region, Country, Segment, and Companies, 2024-2030
... Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antibiotics market size is poised to register 4.79% growth from 2024 to 2030, presenting significant growth prospects ... Read More
-
Specialty Generics Market Size, Trends, Analysis, and Outlook By Type (Injectables, Oral drugs, Others), By Application (Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, Others), By End-user (Specialty pharmacy, Retail pharmacy, Hospital pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Specialty Generics market size is poised to register 11.48% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Opioid-Induced Constipation Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Opioid-Induced Constipation market size is poised to register ... Read More
-
OTC Dry Eye Drops Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Product (With Preservatives, Preservative Free), By Viscosity (Low Viscosity, High Viscosity), By Distribution Channel (Drugstores and Supermarkets, Online Pharmacies, Retail Pharmacies, Others), by Region, Country, Segment, and Companies, 2024-2030
... Pharmacies, Others), by Region, Country, Segment, and Companies, 2024-2030 The global OTC Dry Eye Drops market size is poised to register 7.67% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Pharmaceutical CDMO Market Size, Trends, Analysis, and Outlook By Product (API), By Synthetic, Solid, Liquid), By Type (Traditional API, Highly Potent API, Antibody Drug Conjugate (ADC), Others), By Drug (Innovative, Generics), By Manufacturing (Continuous manufacturing, Batch manufacturing, Biotech, Drug Product, Oral solid dose, Semi-solid dose, Liquid dose, Others), By WorkFlow (Clinical, Commercial), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Batch manufacturing, Biotech, Drug Product, Oral solid dose, Semi-solid dose, Liquid dose, Others), By WorkFlow (Clinical, Commercial), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Generic Drugs Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Geriatric Population and Cost Affordability of Generic Drugs Projected ... Read More
-
Ophthalmic Drugs Market Size, Trends, Analysis, and Outlook By Class (Anti-allergy, Steroidal drugs, Anti-VEGF Agents, Anti-glaucoma, Others), By Disease (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis, Others), By Dosage Form (Gels, Eye, Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments, Others), By Route of Administration (Topical, Local Ocular(Retinal Disorders, Subconjunctival, Intravitreal, Retrobulbar, Intracameral), Systemic), By Dosage Type (Gels, Eye Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments), By Product Type (Prescription Drugs, OTC Drugs), By Product (Branded Drugs, Generic Drugs), by Region, Country, Segment, and Companies, 2024-2030
... Suspensions, Capsules and Tablets, Eye Drops, Ointments, Others), By Route of Administration (Topical, Local Ocular(Retinal Disorders, Subconjunctival, Intravitreal, Retrobulbar, Intracameral), Systemic), By Dosage Type (Gels, Eye Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments), ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
Research Assistance
